Johnson & Johnson (JNJ)

$ 243.57
   
  • Change Today:
    $-0.98
  • 52 Week High: $244.95
  • 52 Week Low: $146.36
  • Currency: US Dollars
  • Shares Issued: 2,406.92m
  • Volume: 4,485,855
  • Market Cap: $586,254m
  • RiskGrade: 87
  • Beta: 0.00

Latest ShareCast News

Johnson & Johnson expects further growth in 2026 as Q4 earnings jump

By Benjamin Chiou

Date: Wednesday 21 Jan 2026

(Sharecast News) - American healthcare and medical device giant Johnson & Johnson matched analysts' estimates with its fourth-quarter results, as earnings jumped on the back of improved sales of cancer and autoimmune drugs.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 243.57
Change Today $ -0.98
% Change -0.40 %
52 Week High $244.95
52 Week Low $146.36
Volume 4,485,855
Shares Issued 2,406.92m
Market Cap $586,254m
Beta 0.00
RiskGrade 87

What The Brokers Say

Strong Buy 6
Buy 8
Neutral 12
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Feb-2026

Time Volume / Share Price
14:34 100 @ $243.57
14:34 100 @ $243.53
14:34 300 @ $243.53
14:34 100 @ $243.47
14:34 100 @ $243.55

Top of Page